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Abstract:  Members of the family Rhabdoviridae are single-stranded RNA viruses and 
globally important pathogens of wild and cultured fish and thus relatively well studied in 
their respective hosts or other model systems. Here, we review the protective immune 
mechanisms that fish mount in response to rhabdovirus infections. Teleost fish possess the 
principal components of innate and adaptive immunity found in other vertebrates. 
Neutralizing antibodies are critical for long-term protection from fish rhabdoviruses, but 
several studies also indicate a role for cell-mediated immunity. Survival of acute 
rhabdoviral infection is also dependent on innate immunity, particularly the interferon 
(IFN) system that is rapidly induced in response to infection. Paradoxically, rhabdoviruses 
are sensitive to the effects of IFN but virulent rhabdoviruses can continue to replicate 
owing to the abilities of the matrix (M) protein to mediate host-cell shutoff and the 
non-virion (NV) protein to subvert programmed cell death and suppress functional IFN. 
While many basic features of the fish immune response to rhabdovirus infections are 
becoming better understood, much less is known about how factors in the environment 
affect the ecology of rhabdovirus infections in natural populations of aquatic animals. 
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immune evasion; non-virion; apoptosis; persistent infections; host-cell shutoff 
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1. Introduction 
Rhabdoviruses are single-stranded RNA viruses and important pathogens of both wild and cultured 
fish throughout North America, Asia, and Europe [1]. Fish are hosts to a number of rhabdovirus 
species including: Infectious hematopoietic necrosis virus (IHNV), Viral hemorrhagic septicemia virus 
(VHSV), Hirame rhabdovirus (HIRRV), Snakehead rhabdovirus (SHRV) Spring viremia of carp virus 
(SVCV), Pike fry rhabdovirus (PRV), Starry flounder virus, and Ulcerative disease rhabdovirus 
(UDRV) [2,3]. Several of these viruses (IHNV, VHSV, and SVCV) are reportable to The World 
Organization for Animal Health (OIE). IHN primarily occurs in salmon and trout [4] and SVC 
primarily afflicts cyprinid fishes [5], while the list of VHS susceptible hosts continues to grow [6]. 
These viruses cause significant mortality and morbidity in both wild and cultured fish [1]. 
Consequently, many rhabdoviruses are well studied in their select fish hosts and the main mechanisms 
of protection of fish against rhabdoviruses are becoming clear. More detailed understanding of 
fish-rhabdovirus interactions will continue to be elucidated as our knowledge of the teleost immune 
system expands.  
In this review, we discuss the general characteristics of fish rhabdoviruses and the factors 
contributing to their pathogenesis. Next, we will consider each major arm of the immune system in the 
context of fish rhabdoviral infection and will evaluate how rhabdoviruses evade or circumvent host 
defenses. Although we primarily focus on fish rhabdoviruses, at times insight gained from two closely 
related mammalian rhabdoviruses—Vesicular stomatitis virus (VSV) and Rabies virus (RABV)—will 
be drawn for comparison. Throughout the review, we will identify research gaps that, if answered, 
would enable a more comprehensive understanding of immunity to fish rhabdoviruses.  
2. The Fish Rhabdoviruses 
2.1. Taxonomy  
The rhabdovirus family contains viruses that are related in terms of both morphological and genetic 
characteristics [7]. Collectively, this growing viral family can infect a vast array of hosts in both plant 
and animal phyla and comprises over 160 species classified among six genera (Vesiculovirus, 
Lyssavirus, Ephemerovirus, Novirhabdovirus, Cytorhabdovirus, and Nucleorhabdovirus) [7]. The best 
studied of all fish rhabdoviruses are IHNV, VHSV, HIRRV and SHRV, which are accepted as 
members of the genus Novirhabdovirus  [2]. SVCV is currently classified within the genus 
Vesiculovirus (typified by VSV) [2], but this taxonomic grouping is likely to change.  
2.2. Structure 
Rhabdoviruses are bullet-shaped, enveloped viruses with a simple negative-sense, single-stranded 
RNA (ssRNA) genome [8]. The typical rhabdoviral genome encodes five basic structural proteins, 
including the nucleoprotein (N), phosphoprotein (P), matrix protein (M), glycoprotein (G) and the 
large polymerase (L) protein (Figure 1A) [9]. Additionally, all rhabdoviruses possess non-coding 3' 
leader and 5' trailer sequences. Members of the genus Novirhabdovirus are distinguished by the Viruses 2012, 4  
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presence a sixth gene located in the genome between the G and the L genes (Figure 1B) encoding a 
non-structural (‘non-virion’ or NV) protein [10,11] that has a role in pathogenesis as discussed below.  
Figure 1. Genome organization and predicted molecular weights (MW) in kilodaltons of 
(A) a typical member of the genus Vesiculovirus, spring viremia of carp virus (SVCV) and 
(B) a typical member of the genus Novirhabdovirus, Viral hemorrhagic septicemia virus 
(VHSV). Predicted SVCV MW are based on [9] and for VHSV on [11]. 
 
2.3. Infection Cycle 
Understanding the viral infection cycle is important to define where the host immune system 
encounters virus-associated molecules. The general rhabdovirus life cycle, derived from VSV, has 
been reviewed extensively elsewhere and involves the five structural proteins found in all 
rhabdoviruses [8]. Briefly, the rhabdovirus enters its target cell by receptor-mediated endocytosis, 
which is triggered following engagement of a cell surface receptor by the viral G protein. The viral and 
endosomal membranes subsequently fuse and the viral nucleocapsid is released into the cytoplasm of 
the host cell. Within the cytoplasm, the viral genes are sequentially transcribed from the genome using 
an RNA-directed RNA polymerase that accompanies the infecting virion, viral proteins are synthesized 
by host cell machinery, and new copies of the genome are synthesized from a full-length, 
single-stranded RNA anti-genome. To package the new virions, the N, L and P proteins, synthesized 
by free ribosomes in the cell cytoplasm, bind to the newly synthesized copies of the viral RNA genome 
to form the ribonucleoprotein (RNP) core, which associates with the M protein to produce the RNP-M 
complex. The G protein is synthesized by endoplasmic reticulum (ER)-bound ribosomes. It is 
glycosylated and further modified within the ER and Golgi apparatus prior to transport and insertion 
into the plasma membranes on the host cell surface. The RNP-M complex migrates to regions of 
the  plasma membrane enriched with viral G proteins. The G protein studded host cell plasma 
membrane is subsequently captured by RNP-M protein complex as it buds from the cell to create fully 
enveloped rhabdovirus.  
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2.4. Disease Manifestations 
Viruses generally follow one of two strategies to ensure survival and transmission: the ‘hit and run’ 
or the ‘hit and stay’ [12]. As acute cytolytic viruses that cause high mortality, fish rhabdoviruses are 
typically considered ‘hit and run’ viruses. Their associated diseases are commonly characterized as 
acute hemorrhagic septicemias that impact multiple organs and present common clinical signs such as 
skin darkening, ascites, and exopthalmia [1]. However, varied forms of disease have been described 
for both IHN (hematopoietic and neurotropic) and VHS (acute, chronic and nervous) in rainbow trout 
(Oncorhynchus mykiss) [13,14], and a persistent infection/asymptomatic carrier state for both VHSV 
and IHNV has been reported that is often, but not always, associated with neural tissues [15–19]. There 
has been relatively little study of these alternative disease manifestations since most laboratory studies 
employ acute challenge models with virus doses sufficient to give reproducibly high mortality.  
2.5. Vaccination Strategies 
In general, survivors of acute fish rhabdoviral infections develop long-lasting immunity, which is 
broadly protective against multiple virus strains of the same species [20,21]. In mammals, long-lasting 
immunity and anamnesis are characteristics of the adaptive immune response whereby memory T and 
B lymphocytes are developed during the initial infection by a pathogen. These cells then maintain 
surveillance for that same pathogen, perhaps for the life of the host, and are able to respond rapidly in 
the event of subsequent infection [22]. Vaccines exploit this characteristic by eliciting an anamnestic 
response prior to initial exposure to a pathogen, thus protecting the host against future infection. A 
variety of approaches have been investigated for vaccinating fish against rhabdoviral infections 
including attenuated strains, inactivated virus, subunit vaccines, and DNA vaccination [23–26]. These 
approaches are all efficacious to a degree (reviewed by [23,24,27]) but—with the exception of the 
IHNV DNA vaccine in Canada [28]—have not been licensed due to concerns regarding safety, 
consistency or cost. To overcome some of the safety concerns associated with DNA vaccines 
(see [29]), new vector constructs that use fish inducible promoters and a suicide gene (the IHNV M 
protein) to limit long-term survival of vaccine DNA in the muscle tissues have been developed and 
show promise [30,31]. 
Experimental DNA vaccines based on the rhabdoviral G protein of IHNV, VHSV, HIRRV and 
SVCV have shown efficacy in a number of different fish host species [32–36]. These G protein 
vaccines have been widely used as tools to probe the mechanisms of protective immunity in fish (for 
review see [37,38]). They elicit an early, nonspecific immune response that cross-protects against other 
viruses but not bacteria, while specific immunity arises later [39–41]. The G protein is the protective 
antigen but only in its correct conformation (for review see [23,24]). Large-scale production of 
glycosylated and folded G proteins has been difficult, limiting their commercial potential as subunit 
vaccines but recent successes with insect-based systems may change this [42]. However, the major 
barrier that remains to commercial rhabdoviral vaccination is the ability to mass vaccinate a large 
number of highly susceptible small fish. All fish rhabdoviral vaccines developed to date require 
individual handling and are typically administered via intramuscular or intraperitoneal injection. Novel Viruses 2012, 4  
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immersion or oral vaccination approaches (i.e., [43]) may eventually provide a solution to this barrier 
(reviewed recently in [44]).  
3. Immune Response 
3.1. Mammalian Paradigm of Anti-Rhabdoviral Immunity  
Conserved pattern recognition receptors (PRRs) of the innate immune system, such as the Toll-like 
receptor (TLR) and RIG-like receptor (RLR) families, detect ‘pathogen associated molecular patterns’ 
(PAMPs) and signal through conserved pathways to activate innate immune effector molecules [45]. In 
general, induction of anti-viral immunity follows recognition of viral nucleic acids by TLRs 3, 7 and 8 
or the RLRs retinoic acid-inducible gene I (RIG-I) and melanoma differentiation-associated gene 5 
(MDA5) and viral glycoproteins by TLRs [46]. This paradigm holds true for rhabdoviruses. For 
instance, engagement of both TLR7 by ssRNA and TLR4 by the viral G protein is required to mount 
an effective immune response against VSV in mice [47–49]. Both RIG-I and MDA5 are required for 
immunity against RABV [50] while RIG-I is also implicated in sensing VSV [51].  
Signaling through PRRs leads to the activation of immune effector molecules, particularly the 
interferon (IFN) system. The IFNs mediate the primary early response to viruses. IFNs are powerful 
set of pleiotropic cytokines with diverse roles in regulating the immune system and inducing an 
anti-viral state. They are divided into three major classes of gene families in mammals: Type I (IFN-α, 
β, ε, κ, τ and ω), Type II (IFN-γ) and Type III (IFN-λ) [52,53]. Type I IFNs are produced by a variety 
of cell types while Type II IFN expression is restricted to immune cells. It is well-established that 
RABV and VSV cannot replicate in type I IFN-alerted cells indicating the importance of type I IFN 
activity in controlling rhabdoviruses (reviewed in [54]). Furthermore, IFN- has been shown to 
reduce infection of murine neurons and neuroblastoma cells by VSV, whereby neuronal nitric oxide 
synthase (nNOS) activity is enhanced by IFN- to elicit viral control via production of reactive nitric 
oxide [55,56]. 
The IFNs signal through the conserved JAK/STAT pathway and up-regulate the expression of >300 
IFN stimulated genes (ISGs) [57,58], which establish the ‘anti-viral’ state [59]. Many of these ISGs 
have direct anti-viral function (i.e., Mx [60]) while the functions of other ISGs remain unknown. The 
ISG protein kinase R (PKR) binds double-stranded RNA (dsRNA) to inhibit viral protein 
synthesis [61]. Furthermore, mice deficient in PKR are more susceptible to VSV infections confirming 
the importance of this PRR in controlling rhabdoviruses [61].  
The adaptive immune system is also an important component of the anti-rhabdoviral immunity. 
This arm of the immune system employs two classes of lymphocytes—B cell and T cells—that very 
specifically recognize viral antigens. B cells are absolutely essential for survival to VSV infection in 
mice [62]. They secrete neutralizing antibodies directed against the viral G protein, and are highly 
protective against VSV. Due to the repetitive, polyvalent nature of G protein epitopes on VSV 
virions—a typical characteristic of T cell independent antigens—these neutralizing antibodies are 
initially (days 2–6) produced in a T cell independent manner and represent predominantly the IgM 
isotype. Their secretion later becomes T cell dependent generating long-lived antibodies from both the 
IgM and IgG isotypes [63]. In mammals, there are two major T cell subsets: Cytotoxic T lymphocytes Viruses 2012, 4  
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(CTL) that typically utilize the CD8 co-receptor and helper T cells (TH) that utilize the CD4 
co-receptor [22]. Studies in immune deficient mice highlight the requirement of CD4+ T cells for an 
optimal immune response against VSV and show that while CD4+ T cells can compensate for the their 
absence, CD8+ T cells also have anti-VSV activity [62]. In mammals, CTLs are responsible for 
specific cell-mediated cytotoxicity (CMC) while natural killer (NK) cells of the innate immune system 
are the primary effectors of nonspecific CMC [22]. Mammalian NK cells participate in the early innate 
antiviral immune response through non-antigen specific CMC of infected targets and secretion 
of IFN-γ, while the CTL response occurs at later time point, and is MHC class I-restricted and 
antigen-specific. 
3.2. Viral Recognition in Fish 
Pattern recognition of rhabdoviruses in fish is likely to mirror that observed in mammals [64]. 
Although there is limited functional characterization of receptor binding activity and signaling, teleost 
fish are known to possess the major TLR families plus an expanded set of unique non-mammalian 
TLR genes and gene variants (reviewed by [65,66]), as well as genes encoding RIG-I, MDA5, 
laboratory of genetics and physiology 2 (LGP2) and the associated signaling molecule mitochondrial 
antiviral signaling (MAVS) protein [67–69]. Fish possess orthologs to typical anti-viral TLRs 
including TLR3, TLR7 and TLR8 [70–72], in addition to novel TLRs (TLR22) that appear to bind 
different forms of RNA [73], suggesting there is conservation in recognition of viral nucleic acids. In 
contrast, most fish species either lack TLR4 or possess highly divergent TLR4-like genes relative to 
mammalian TLR4 (e.g., zebrafish (Danio rerio)) [74]. Thus, the phenomenon of viral glycoprotein 
recognition ascribed for TLR4 in mammals is unlikely to be conserved in fish species. However, the G 
proteins of novirhabdoviruses are known to trigger the synthesis of IFN in rainbow trout cells 
suggesting that capacity of the innate immune system to recognize rhabdoviral glycoproteins is 
conserved [75,76]; although the PRR(s) involved in this interaction are currently undetermined. The 
IFN response to the G protein can be triggered in both immune [75] and non-immune cells [76] and 
IFN induction is dependent on a peptide region that contains a canonical integrin binding site [77]. 
Other PRRs such as RIG-I, MDA5 and LGP2 (and their associated adaptor MAVS) activate the 
IFN system  when overexpressed in fish cells, which correlates with protection against rhabdoviral 
infection [69,78].  
3.3. Innate Immune Response to Fish Rhabdoviruses 
Characterization of the innate immune response to fish rhabdoviruses has accelerated due to the 
genomic information available for model and commercially-important fish species. Genes encoding 
critical cytokines, chemokines, and other innate effectors have been identified in fish including those 
encoding both type I IFNs (also called IFNφ) and type II IFNs (also called IFNγ) [79–89]. Fish type I 
IFNs (IFNφ) are split into two major groups, which differ in the number of conserved cysteine (C) 
residues (group I—2C and group II—4C) [83,84] and appear to bind different receptors [90,91]. In 
general, group I IFNs are expressed in a wide range of tissue types while group II IFNs are more 
abundant in hematopoietic-derived tissues and cells [84]. Multiple gene copies of IFNγ exist in fish 
species but these genes are not duplicated to the same extent as the type I IFNs (reviewed in [92]). The Viruses 2012, 4  
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phylogenetic relationships among fish IFNs and the associated nomenclature are confusing and 
disputed; the review by Zou and Secombes [92] provides a useful table summarizing the fish IFNs 
identified to date. 
Like their mammalian counterparts, replication of fish rhabdoviruses is inhibited by pre-activation 
of the IFN system regardless of the method used, including using IFN-containing supernatants [93,94], 
poly I:C [95], rhabdoviral G protein [39,40,75] or recombinant IFN [96,97]. Prior to the identification 
of the IFN genes themselves, activation of a functional IFN response was inferred by virus plaque 
reduction [98], transcription of the Mx gene or other ISGs (i.e., [99–101] and many other studies), or 
activation of an Mx promoter-reporter assay [102]. Early studies clearly indicate functional IFN in sera 
derived from fish infected with VHSV [93] , IHNV [98] or SVCV [94]. Later studies confirmed these 
results and demonstrate transcriptional up-regulation of both group I and II IFN genes after infection 
with these same viruses [84,85,103]. IFNγ genes are also regulated early in rhabdoviral infection [85].  
Rhabdoviral infections are controlled by fish group I and II IFNs. Recombinant group I IFNs inhibit 
rhabdoviral replication [84,96,97,103,104] while the effects of group II IFNs on rhabdoviruses vary 
(e.g., [84]). A recent study demonstrates that recombinant group II IFNs protect zebrafish against 
SVCV infection and induce a rapid and transient up-regulation of ISGs whereas those from group I 
up-regulate both ISGs and pro-inflammatory cytokines in a more sustained fashion [103]. Similarly, 
fish IFNγ also elicits an immune response related to controlling viruses. Recombinant IFNγ  
up-regulates a number of ISGs [105] and displays anti-viral activity [106] in a variety of Atlantic 
salmon (Salmo salar) cell-lines. At least some of the anti-viral activity ascribed to IFNγ may be due to 
the ability of IFNγ to increase transcription of group I IFNs [106]. However, recombinant IFNγ does 
not improve survival of zebrafish infected with SVCV [103], questioning whether rhabdoviruses are 
directly controlled via the activity of this cytokine. 
Rhabdoviral infection and/or G protein vaccination induce a characteristic transcriptional pattern 
dominated by ISGs that are conserved throughout vertebrates, as well as the expression of novel 
antiviral genes (for a comprehensive review see [107]). Vaccination with the rhabdoviral G protein 
primes the systemic up-regulation of these ISGs [108–110] and the timing of this response correlates 
with nonspecific protection from virulent IHNV and VHSV challenge [39,40]. Fish rhabdoviral 
infection also result in a rapid IFN and ISG response—similar to that observed early after G protein 
vaccination—which correlates with virus levels in the tissues, but does not necessarily correlate with 
protection [101,111–113]. This paradox is suggestive of a virus-host race in which rapid replication of 
the fish rhabdoviruses competes kinetically against mobilization of innate immune mediators. Rapid 
replication is a hallmark of highly virulent IHNV strains [114–116]. Rainbow trout progeny groups 
with greater genetic resistance to IHNV have lower in vivo viral replication starting at less than 24 h 
post-infection [117], which is a relatively limited time frame for the host to induce a response that 
relies on new protein synthesis (i.e., the IFN system). This suggests that constitutive or other innate 
barriers to viral replication are also important for overall disease resistance. Other studies have found 
that VHSV resistance in trout is correlated with ex vivo replication of VHSV in fin tissues, implicating 
epidermal tissues as pivotal in the anti-VHS defense system [118–120]. Host-virus dynamics at virus 
entry points (i.e., the fins [121]) may help limit the internal spread of viral infection by alerting 
systemic sites via IFNs and other cytokines.  
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3.4. Humoral Immune Response to Fish Rhabdoviruses 
Neutralizing antibodies induced by infection and/or vaccination are critical components of long-
term adaptive immunity to fish rhabdoviruses (reviewed in [122]). Passive immunization with sera 
containing neutralizing antibodies protects recipient juvenile trout from IHN and Pacific herring from 
VHS, even when titers fall below detectable levels [40,123–125]. Most studies of fish rhabdoviruses 
have focused on the highly protective neutralizing antibody response but it is possible that non-
neutralizing or other types of antibodies may also play a role. In vitro rhabdoviral neutralization is 
complement-dependent but the exact mechanism by which complement aids viral neutralization is still 
unclear [126]. Neutralizing antibodies are unlikely to play a role in surviving the acute infection phase 
in coldwater fish species since neutralizing antibodies typically are not detectable until several weeks 
post-infection. Study of attenuated or low virulence virus types indicates that a certain threshold of 
virus replication must occur for fish to develop a broadly protective antibody response, even if a robust 
innate response is induced [113,127].  
Lorenzen and LaPatra [122] published a comprehensive review of the antibody response to fish 
rhabdoviruses in 1999, and since then, this area has not received much new attention. Certainly, studies 
of the G protein DNA vaccines over the past decade have reaffirmed the central role of neutralizing 
antibodies in protective immunity [33,34,128–133]. However, genomic approaches combined with 
functional studies have brought exciting new insights into B cell biology in teleost fish. Fish B cells 
show phagocytic behavior suggesting that fish B cells may also function as part of the innate immune 
system [134]. Furthermore, it is now known that teleost fish possess three or more immunoglobulin 
isotypes including IgM, IgD and IgT (IgT is also called IgZ in zebrafish) [135–137]. A recent study 
indicates that B cells expressing IgM respond to antigenic stimulation in systemic tissues while B cells 
expressing IgT are key to the mucosal immune response [138]. To date, there has been no 
characterization of IgT during fish rhabdoviral infections. However, tools such as monoclonal 
antibodies to fish IgM and IgT now exist [138,139], which will allow the characterization of mucosal 
immunity and its relationship to systemic protection against rhabdoviruses. Finally, there has been 
much progress in unraveling the complexity of the fish complement system [140], which may help to 
finally define which complement components contribute to virus neutralization.  
3.5. Cellular Immune Response to Fish Rhabdoviruses 
Although DNA vaccination with the novirhabdoviral G protein triggers production of protective 
neutralizing (and perhaps other) antibodies, high levels of specific protection after DNA vaccination 
are also observed without detectable neutralizing antibodies [33,130] indicating a potential role for 
specific cellular immunity. Major advances have been made recently in our understanding of fish T 
cells (as reviewed in [141]). Teleost fish possess a wide range of T cell associated genes, including 
genes that encode T cell receptor chains and various other T cell associated co-receptors, co-stimulatory 
molecules and cytokines [141]. Many of these genes show up-regulated expression following 
rhabdoviral infection and/or G protein DNA vaccination [110,142]. There is a limited understanding of 
the role T cells play during fish rhabdoviral infection with most work focusing on cell-mediated 
cytotoxicity (CMC) (discussed below). However, VHSV infection and DNA vaccination with the Viruses 2012, 4  
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VHSV G protein induces clonal expansion of T cells, as shown by spectratype analysis of the 
complementarity-determining region 3 (CDR3) of the TCR-β chain [143,144], supporting a role of 
teleost T cells in controlling this virus. Interestingly, the dominant CDR3 profiles are the same for both 
VHSV infection and G protein DNA vaccination suggesting that important T cell epitopes are 
localized within the G protein. Future studies examining the role of T cells during rhabdoviral 
infection will benefit from new reagents that can discriminate among T cell subsets (reviewed 
in [141]), including monoclonal antibodies against the CTL surface marker CD8 [145].  
Studies using rainbow trout, channel catfish (Ictalurus punctatus), common carp (Cyprinus carpio) 
and crucian carp (Carassius carassius) provide evidence for both specific and nonspecific CMC in fish 
(reviewed in [146,147]). Two different cell types are responsible for nonspecific CMC in channel 
catfish, the nonspecific cytotoxic cells (NCC) and NK-like cells [148–150]. Common carp neutrophils 
also possess nonspecific CMC activity, evidenced by spontaneous killing of human tumor cell 
lines [151]. Studies of mammals and other vertebrate species indicate that NK cell activity is mediated 
by many different receptor types that can be specific to an individual animal species or even to a cell 
lineage [152]. Candidate NK receptor families in fish include the novel immune type receptors 
(NITRs), novel Ig-like transcripts (NILTs), leukocyte immune type receptors (LITRs), and possibly 
others (reviewed in [152]). Genomic characterization of fish species has enabled the identification of 
these polymorphic and polygenic receptor families, but there has been limited validation that these 
receptors have a functional role in NK activity.  
Functional studies of specific CMC were made possible in fish following the development of 
isogenic fish and major histocompatibility complex (MHC) I matched cell lines for both crucian carp 
and rainbow trout [153–155]. Somamoto et al. [155] demonstrated that peripheral blood and kidney 
derived lymphocytes from crucian carp exhibit a specific CMC response to MHC-matched cells 
infected with Crucian carp hematopoietic necrosis virus (CHNV; an uncharacterized fish rhabdovirus). 
Similarly, peripheral blood lymphocytes from rainbow trout infected with VHSV exhibit significant 
CMC to MHC class I matched target cells infected with VHSV but not to VHSV infected xenogeneic 
targets [154]. However, rainbow trout survivors re-exposed to VHSV mounted a kinetically faster, 
VHSV-specific CMC response, as well as a nonspecific CMC response against VHSV infected 
xenogeneic targets (starting at 11 days post-infection). The delayed nonspecific CMC response in trout 
contradicts the mammalian paradigm where primary CMC is nonspecific and results from NK cell 
activity while later CMC is pathogen-specific due to clonal expansion and action of virus specific 
CTLs [22]. Taken together, these studies suggest a role for cellular immunity—particularly CMC—in 
the host response to fish rhabdoviruses. However, more basic research is needed to definitely identify 
the cells that contribute to key cellular effector functions in fish. 
3.6. Modulation of Immunity by Environmental Parameters 
For poikilothermic vertebrates, temperature is a critical factor in host-pathogen interactions because 
most aspects of the host’s physiology, including the strength and speed of the immune response, as 
well as the replication rate of the pathogen are temperature dependent [156]. Among fish 
rhabdoviruses, it is well known that the severity of VHS and SVC alters with changing temperatures in 
the spring and fall [157,158]. However, while the in vitro replication rate of fish rhabdoviruses Viruses 2012, 4  
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increases with temperature to a maximum upper limit [158], the severity of disease is generally less at 
higher temperatures which may be due to the greater efficiency of the fish immune response [159,160]. 
As such, modulation of temperature has been explored as a basis for protection or vaccination of fish 
against rhabdovirus infections [161,162].  
At optimal temperatures, fish surviving rhabdovirus infections develop a robust immune response 
and clear the virus below detectable levels [163]. In contrast, fish held at lower temperatures may rely 
more on innate immunity and have inhibited or delayed specific immune responses [156,164,165]. Low 
or cold water temperatures are also linked to development of persistent rhabdoviral infections [15,17]. 
For example, rainbow trout held at 4 °C had detectable VHSV in the brain for over 400 days post-infection 
and displayed no clinical signs of VHS or detectable serum neutralizing antibody titers [17]. These 
studies support the hypothesis that rhabdoviral persistence is related to suppression of the adaptive 
immune response. However, it is not clear whether individuals become long-term carriers or if the 
virus persists by cycling in the population among naïve and/or convalescent hosts [18]. If individuals 
are truly persistently infected, it raises interesting questions of how normally acute cytolytic viruses 
modulate replication and limit cytopathology.  
Other environmental factors may also affect disease resistance in fish. Intriguingly, the CMC 
response in fish immunized with the N protein of VHSV was suppressed during winter months despite 
constant water temperature and light regimen; this result may indicate that endogenous biological 
variables (e.g., reproductive cycle) or other seasonal factors influence anti-viral immunity [166]. 
Resistance to fish rhabdovirus infections has also been shown to be modulated by diet [167,168]. 
Thus,  in addition to temperature, other environmental factors such as age, diet, seasonality and 
reproductive status will be important areas for study in order to fully understand the immune response 
to fish rhabdoviruses.  
4. Rhabdoviral Immune Evasion Mechanisms 
4.1. Overview 
A pathogenic virus must possess some mechanism to evade or limit innate host defenses, disrupt 
normal cellular processes, and gain preferential transcription and translation of its own genes [169]. 
Viruses have evolved many strategies to overcome host defenses. In response, the vertebrate immune 
system continuously evolves counter-strategies against the virus. This co-evolutionary arms race has 
led to great diversity in the host-virus relationship as viruses evolve new strategies to limit, evade or 
otherwise subvert the immune system. Here we will outline important aspects of immune evasion by 
mammalian rhabdoviruses. Next, we will consider evidence indicating a critical role for the fish 
rhabdoviral M and NV proteins in immune evasion.  
4.2. Mammalian Rhabdoviral Immune Evasion 
As mentioned above, rhabdoviruses cannot replicate in IFN-primed cells (reviewed in [54]). 
However, the rapid and strong induction of the host IFN system following detection of invading 
rhabdoviruses is not sufficient to prevent the replication of virulent rhabdoviruses. Rhabdoviruses are 
thought to directly interfere with critical immune effector functions including the interferon system to Viruses 2012, 4  
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evade immune control. They may also interfere with programmed cell death processes (apoptosis) and 
mediate global inhibition of host cellular gene expression and thereby inhibit transcription-dependent 
host cell defenses, a phenomenon known as host-cell shutoff [170]. RABV and VSV use very different 
strategies to disrupt mammalian host defenses. RABV relies on the P protein to limit IFN production, 
antagonize IFN signaling and directly interfere with IFN-induced antiviral molecules [171,172]. In 
contrast, VSV relies on the M protein to facilitate host-cell shutoff [170]. This mechanism limits RNA 
transcription by suppressing all host RNA polymerases [170], inhibits nucleocytoplasmic transport by 
blocking nuclear pore components [173], and prevents translation of host genes into proteins [174]. 
Shutoff of host cellular processes likely increases the resources available for viral transcription and 
translation, while decreasing production of anti-viral host proteins.  
Rhabdoviral infection induces apoptosis in infected mammalian cells (reviewed in [169]). 
Apoptosis is a type of programmed cell death that creates characteristic morphological and biochemical 
changes and is mediated by proteolytic enzymes called caspases [175]. In infection-associated 
apoptosis, there arises a common question concerning whether the cell death is due to viral factors or 
to the host antiviral response. Both factors may be responsible. For instance, reverse genetic analysis 
of VSV revealed that apoptosis occurs by two distinct pathways; one pathway is associated with the M 
protein while the other pathway relies on host gene expression [176,177]. The M protein-mediated 
apoptosis may be a byproduct of the host-cell shutoff activity, since the suppression of host cellular 
gene expression and translation is most likely incompatible with long  term cell survival. This 
hypothesis is supported by the finding that host-cell shutoff and apoptosis are genetically correlated 
and involve the mitochondrial (intrinsic) pathway of apoptosis and caspase 9 [176,177]. The second 
pathway is hypothesized to result from a typical host anti-viral response and requires both new host 
gene expression and caspase 8 to occur [176,178]. However, rapid induction of apoptosis is not 
effective at inhibiting VSV replication in most cell types suggesting that this is not necessarily an 
effective anti-viral response [177,179].  
Antigenic/epitope variation is another strategy used by certain viruses, bacteria and parasites to 
evade the immune system and escape from protective humoral and/or cellular immune responses. 
Among viruses, this strategy is best known as an important feature in the biology of Influenza virus or 
Human immunodeficiency virus [180]. For rhabdoviruses, evidence for immune selection by antibody 
escape has been shown in variant laboratory strains of both RABV and VSV whereby escape mutants 
lose detectable reactivity with monoclonal antibodies specific for neutralizing epitopes on the virus 
G  protein [181,182]. Field isolates of VSV from endemic areas show some evidence of immune 
selection [183,184]. Nevertheless, while playing a role in virus evolution, this strategy does not appear 
to be a critical factor in the persistence or epidemiology of rhabdoviruses in that antigenic strains of 
RABV and VSV continue to circulate in endemic areas without sequential replacement. Moreover, 
immunity conferred by infection or vaccination with one strain is broadly protective and likely due to 
conservation of some neutralizing epitopes on the G proteins of rhabdoviruses [185].  
4.3. Fish Rhabdoviral Immune Evasion: Role for M Protein 
Showing similarity to VSV, the fish novirhabdovirus IHNV possesses host-cell shutoff ability that 
is specifically mediated by the M protein [186]. Transfection of cultured Chinook salmon embryonic Viruses 2012, 4  
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cells (CHSE-214) with the IHNV M protein also induces host morphological changes consistent with 
apoptosis [186], indicating cell death can occur in the absence of live virus. In contrast, there is no 
observable molecular or cellular effect following transfection of the IHNV P protein [186]. To date, 
host cell-shutoff has only been documented for IHNV and not for the other fish rhabdoviruses. The 
availability of reverse genetic tools for IHNV, VHSV and SHRV [187–189] would allow further 
dissection of this response in fish, such as the development of M protein mutants deficient in host-cell 
shut off activity.  
4.4. Fish Rhabdoviral Immune Evasion: Role for NV Protein 
Attempts to identify a function for the NV protein have led to contradictory results. Overexpressed 
IHNV NV causes cell rounding in CHSE-214 cells but not apoptosis leading to speculation that NV 
interacts with host cytoskeletal elements [186]. SHRV NV is dispensable for efficient replication in 
cultured fathead minnow cells (EPC cell line; [190,191]) and in vivo virulence in zebrafish [188,192]. 
In contrast, the IHNV NV is essential for optimal growth in EPC cells and virulence in rainbow 
trout  [193]; a similar observation was made using a VHSV NV knockout in the yellow perch 
(Perca flavescens) host [194]. Two new studies now indicate a role for NV in delaying apoptosis and 
suppressing the host IFN system [187,195].  
Many viruses possess strategies to delay or prevent apoptosis to prolong viral replication. Recently, 
Ammayappan and Vakharia [187] demonstrated that the VHSV NV protein has the ability to delay the 
onset of apoptosis in cell culture. In their study, recombinant VHSV lacking NV induced apoptosis 
sooner than wild-type VHSV. The anti-apoptotic function could be recovered by the IHNV NV [187], 
suggesting the NV protein’s anti-apoptotic function may be conserved despite low amino acid 
similarity between the VHSV and IHNV NV proteins (~48%) [193]. Furthermore, VHSV infection 
induces the activity of the initiator caspases 3, 8, and 9 [187] implicating the involvement of multiple 
apoptotic pathways that may be induced by specific viral components (e.g., M protein) and/or by host 
components (e.g., mediated by IFN, PKR etc.). More studies are needed to determine which apoptotic 
pathway(s) are being targeted for delay by the VHSV NV protein.  
A second recent study indicates that the NV also functions to limit the host IFN response in fish. 
Choi  et al. [195] demonstrated that recombinant IHNV lacking the NV gene induced greater 
transcription of the rainbow trout Mx and IFN1 in RTG-2 cells and had higher levels of functional 
IFN, as measured by an Mx reporter assay [102]. The study demonstrated that the NV protein is 
actively transported to the nucleus and that nuclear transport and anti-IFN activity were dependent on a 
unique nuclear localization signal (NLS). Although the NLS was conserved among all IHNV strains 
examined, it was not conserved in VHSV indicating that further study is needed to determine if the NV 
from all novirhabdoviruses function in a similar manner. Furthermore, it would be interesting to 
determine if the anti-apoptotic activity of the NV protein (described above for VHSV) is genetically 
correlated with the ability to limit IFN and is dependent on nuclear localization.  
4.5. Limited Evidence for Antigenic Escape 
Analogous to RABV and VSV, isolates of fish rhabdoviruses show a level of antigenic 
diversity [4,5,157,196], and respond to immune selection with monoclonal antibodies by generating Viruses 2012, 4  
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escape mutants [197]. Analysis of the amino acid sequences encoded by the G protein gene of a 
diverse set of field isolates of IHNV showed that the maximum diversity occurred in the central region 
of the protein that contained many of the antigenic determinants [198] suggesting that immune 
selection may be helping to drive virus evolution. This central region of the G gene was used by 
Kurath et al. [199] to show that, compared to stocks of wild anadromous salmonids in their native 
range, genetic diversity was highest among trout populations reared in aquaculture where a high rate of 
virus replication/infection and the presence of large numbers of recovering/recovered animals would 
be expected to drive a greater level of immune selection. Comparison of the nonsynonymous and 
synonymous substitutions present in the G gene sequences obtained from cultured rainbow trout IHNV 
isolates suggests the possibility that some specific amino acids may be under positive selection [200]. 
Furthermore, this phylogenetic analysis revealed that isolates of IHNV from trout aquaculture 
appeared to be undergoing a higher rate of evolution with the most recent isolates positioned at branch 
tips, unlike isolates from wild populations [199]. However, within the range of genetic strains or 
serological variants that comprise a given species of fish rhabdovirus, laboratory studies show broad 
protective immunity in fish that recover from infection with a given strain of the virus or are 
vaccinated using antigens from a specific strain [20,21]. Thus, while these data indicate that immune 
selection may be an important driver of genetic diversity and virus evolution, fish rhabdoviruses 
appear to be incapable of undergoing complete antigenic escape, perhaps due to the presence of a 
functionally essential, and thus highly conserved, regions of the G protein. However, more study is 
needed of the immunological responses to alternate disease manifestations, such as persistent 
infections, to determine how the virus evades the host antibody response.  
5. Future Directions 
Interactions between the immune system and rhabdoviruses are well studied for certain fish 
rhabdoviruses in certain hosts (i.e., IHNV and VHSV in salmonid species), but there are still gaps in 
our knowledge. Over the past decade, much advancement has been made in understanding the genomic 
architecture of the fish immune system, which will facilitate future functional studies to fill in these 
gaps. There has also been progress in identifying the viral determinants of immune evasion for VHSV 
and IHNV using reverse genetics, but it is not known if these strategies are broadly conserved among 
all members of the genus Novirhabdovirus. Additionally, more work is needed to better define the 
detailed mechanisms underlying these evasion strategies. The knowledge gaps are even greater for the 
SVCV and other vesiculo-like viruses. It is likely that the M protein-mediated host-cell shutoff is 
conserved in SVCV, but other novel mechanisms may also exist. For probing some of these questions, 
zebrafish may serve as an excellent model because many tools are available to genetically manipulate 
this fish species. However, there should be some caution with relying exclusively on model fish 
species as some aspects of the host-pathogen relationship may not be represented during infections of 
non-natural hosts.  
How highly virulent fish rhabdoviruses persist in populations is a long unanswered question. The 
answer will likely vary depending on many factors, including the rhabdoviral species, host species, 
host life history, types of vectors, environment, and degree of anthropogenic manipulation. However, 
understanding how fish rhabdoviruses interact with the host immune system can provide a new Viruses 2012, 4  
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perspective on this question. Infection with fish rhabdoviruses is often acute and associated with high 
mortality; survivors typically clear the virus and develop broadly protective immunity to re-infection. 
However, if this scenario were always to occur, a reduction in the number of susceptible hosts through 
mortality and increased herd immunity among recovered animals should theoretically drive the virus 
out of any natural population. There are several alternatives to this scenario that include, but are not 
limited to: (1) ‘immune’ fish can replicate the virus to sufficient levels for viral shedding and 
transmission to occur, (2) endogenous or exogenous parameters suppress fish immunity such that 
survivors can be re-infected, (3) fish rhabdoviruses have a broad enough host range that susceptible 
hosts are always available, or (4) these normally acute viruses can also persistently infect a small 
number of individuals to ensure survival when there are no susceptible hosts. Although there are a 
number of studies indicating that fish rhabdoviruses can establish persistent infection (described 
earlier), there remains a possibility that the perceived persistence in these studies reflects infection 
cycling among previously exposed individuals or in non-natural conditions. Distinguishing among 
these hypothesized scenarios will require the merging of immunology and epidemiology, which may 
be the key to unraveling the disease ecology of fish rhabdoviruses.  
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